SelectQuote Q4 Earnings Call Highlights
SelectQuote (SLQT) reported Q4 Healthcare Services membership at 109,000, with expected revenue decline of 10-15% in fiscal 2027 due to the Inflation Reduction Act. Senior segment revenue fell 4% to $576M but maintained 26% EBITDA margins. Life insurance revenue rose 8% to $186M. The company guided fiscal 2027 revenue at $1.35B-$1.45B and adjusted EBITDA at $90M-$115M, with cash flow doubling.
How this was made
The 30-second read
Why it matters
The guidance suggests a 14% revenue decline year‑over‑year, which may trigger a re‑rating of the stock by analysts and affect investor sentiment.
Market read
Earnings and guidance release for a mid‑cap insurer; primary driver of short‑term market reaction.
What to watch
Potential upside from the new Kansas pharmacy facility efficiency gains and AI cost‑savings.
Background
SelectQuote is a U.S. insurance brokerage that reported Q4 results and FY2027 outlook, highlighting membership trends, segment performance, and cost‑saving initiatives.
Ticker impact
SelectQuote disclosed Q4 results and FY2027 guidance, including revenue decline to $1.35‑$1.45B and adjusted EBITDA $90‑$115M.
Potential short‑term downside as investors price in revenue decline.
Guidance is the first public disclosure of FY2027 outlook; the magnitude of the revenue drop is material for a mid‑cap insurer.
Market effects
Healthcare insurance brokerage sector may see valuation pressure as revenue outlook weakens.
U.S. insurance and brokerage markets could experience modest sell‑off.
Limited; impact confined to U.S. listed insurers.
Counterpoint
If the AI‑driven cost reductions materialize, the stock could rebound despite short‑term revenue decline.
Key entities
- ExecutiveRyan Clement
Chief Financial Officer providing guidance.
- ExecutiveBob Grant
President discussing pharmacy facility efficiency.
